Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6121
Prostate Cancer – Page 14 – The Robotic Surgeon – Domenico Savatta, M.D.

Category: Prostate Cancer

  • Prostate Biopsy: Side Effects and Risks

    UroToday – EAU 2007 – Session on Prostate Biopsy 1 The 7,074 biopsies were performed in 5,153 men. Minor complications included hematuria >1 day (13.8%), hematospermia (35.8%), and rectal bleeding (2.1%). Major complications were prostatitis, epididymitis, fever >38C, rectal bleeding >2 days, and urinary retention, all <1.0%. This study validates the safety of TRUS biopsy…

  • HIFU and cryosurgery for prostate cancer

    UroToday – EAU 2007 – Minimally Invasive and Other Treatment Strategies in Localized Prostate Cancer The authors conclude that this treatment modality is appropriate for patients with localized CaP who are not candidates for surgery. The oncological outcomes appear inferior to rates reported for radiotherapy and surgery. 2 abstracts were summarized from the EAU’s meeting:…

  • Testosterone replacement after seeds for prostate cancer

    Testosterone Replacement May Be Safe After Prostate Cancer NEW YORK (Reuters Health) Mar 23 – Testosterone replacement therapy (TRT) appears safe for men who experience hypogonadal symptoms after brachytherapy for prostate cancer. “Men who have undergone potentially curative treatment for prostate cancer but also suffer from severe effects of hypogonadism may benefit from a trial…

  • Prostate Cancer: Surgery for locally advanced prostate cancer

    Prostatectomy Effective for SV-Negative Locally Advanced Prostate Cancer At a mean follow-up of 37.2 months (median, 21.2 months), the pT3 (pT3a plus pT3b) patients’ overall and disease-specific 10-year survival rates were 77% and 92%, respectively, and at 15 years, 52% and 75%. These results are similar to those of previous studies for overall survival of…

  • Prostate Cancer: Is PSA Screening effective

    There were 2 articles summarized from the EAU 2007 conference on Urotoday. They seemed to be conflicting, with one saying that delaying therapy did not seem to hurt many people and the other concluding that screening helped. UroToday – EAU 2007 – Session on Prostate Cancer Screening: Dr. Pelzer, Innsbruck presented data that the pathologic…

  • Prostate Cancer: Obese men are more likely to have worse pathology reports than expected

    Dr. Koop – Biopsy Underestimates Prostate Cancer in Overweight Men: Researchers compared the biopsy grade to the cancer grade following radical prostatectomy, which is the removal of the prostate. In 1,113 men who underwent radical prostatectomy between 1996 and 2005 within the Shared Equal Access Regional Cancer Hospital database, 299 men, or 27 percent, had…

  • Prostate Cancer: Researchers find genetic links

    Scientists have identified several genetic risk factors for prostate cancer, shedding new light on the cause of a leading worldwide cancer killer among men that hits U.S. blacks especially hard. ‘The importance of it is that this is the first real evidence of the genetic basis of prostate cancer,’ said Dr. Brian Henderson, dean of…

  • Do you need to remove the whole prostate if I have prostate cancer surgery

    This is one of the most common questions that patients ask me, especially if the cancer is confined to one area on biopsy. With robotic surgery I am able to remove part of a prostate if I want to, and I often do that for BPH operations. For prostate cancer it is not the correct…

  • Lowering PSA and PSA velocity: Are we doing the best thing

    screening prostate biopsy